The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.
作者信息
Buckett W R, Marjoribanks C E, Marwick F A, Morton M B
出版信息
Br J Pharmacol Chemother. 1968 Mar;32(3):671-82. doi: 10.1111/j.1476-5381.1968.tb00466.x.
Abstract
摘要
相似文献
1
The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.
Br J Pharmacol Chemother. 1968 Mar;32(3):671-82. doi: 10.1111/j.1476-5381.1968.tb00466.x.
2
On the pharmacology of Org 6338 (2beta, 16beta-dipiperidino - 5alpha - androstan - 3alpha - ol acetate dimethobromide), a new steroidal neuromuscular blocking agent.
J Pharm Pharmacol. 1975 Oct;27(10):721-7. doi: 10.1111/j.2042-7158.1975.tb09390.x.
3
Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat.
J Pharm Pharmacol. 1972 Oct;24(10):762-72. doi: 10.1111/j.2042-7158.1972.tb08880.x.
4
The potentiation of neuromuscular blocking agents by quinidine.
Anesthesiology. 1967 Nov-Dec;28(6):1036-41. doi: 10.1097/00000542-196711000-00016.
5
Pharmacology of ORG NC 45 compared with other non-depolarizing neuromuscular blocking drugs.
Br J Anaesth. 1980;52 Suppl 1:11S-19S. doi: 10.1093/bja/52.suppl_1.11s.
6
The interaction of hexafluorenium with other neuromuscular blocking agents in man.
Anaesthesist. 1966 Mar;15(3):75-8.
7
The action of certain neuromuscular blocking agents on the laryngeal muscles in the dog.
Laryngoscope. 1972 Mar;82(3):483-90. doi: 10.1288/00005537-197203000-00017.
8
[Comparative sensitivity of neuro-muscular synapses of different muscles toward d-tubocurarine chloride and alpha-truxillic acid].
Farmakol Toksikol. 1967 Mar-Apr;30(2):152-6.
9
Further studies on the site of action of nicotinic blocking drugs.
Eur J Pharmacol. 1973 Aug;23(2):211-5. doi: 10.1016/0014-2999(73)90058-7.
10
The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man.
Br J Anaesth. 1967 Oct;39(10):775-80. doi: 10.1093/bja/39.10.775.
引用本文的文献
1
Influence of neuromuscular transmission and Na channel inhibitors on strength-duration relationship in isolated slow- and fast-twitch muscles.
J Muscle Res Cell Motil. 2025 Jul 28. doi: 10.1007/s10974-025-09702-1.
2
Alterations in neuromuscular junction morphology with ageing and endurance training modulate neuromuscular transmission and myofibre composition.
J Physiol. 2025 Jan;603(1):107-125. doi: 10.1113/JP285143. Epub 2024 Jan 3.
3
Allosteric inhibition of muscle-type nicotinic acetylcholine receptors by a neuromuscular blocking agent pancuronium.
PLoS One. 2023 Oct 12;18(10):e0292262. doi: 10.1371/journal.pone.0292262. eCollection 2023.
4
Neuromuscular block.
Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S277-86. doi: 10.1038/sj.bjp.0706404.
5
Induction of Na+/K(+)-ATPase activity by long-term stimulation of nicotinic acetylcholine receptors in C2C12 myotubes.
Br J Pharmacol. 1994 Feb;111(2):459-64. doi: 10.1111/j.1476-5381.1994.tb14758.x.
6
A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants.
Br J Pharmacol. 1980 Nov;70(3):501-6. doi: 10.1111/j.1476-5381.1980.tb08730.x.
7
Pancuronium bromide (Pavulon) evaluation of its clinical pharmacology.
Can Anaesth Soc J. 1971 Sep;18(5):512-35. doi: 10.1007/BF03026014.
8
The effect of pancuronium bromide on plasma norepinepharine and cortisol concentrations during thiamylal induction.
Can Anaesth Soc J. 1974 Mar;21(2):147-52. doi: 10.1007/BF03013107.
9
The effect of pancuronium on reflex regulation of heart rate in man.
Can Anaesth Soc J. 1974 Mar;21(2):139-46. doi: 10.1007/BF03013106.
10
Localization of 14C-pancuronium by histo- and wholebody-autoradiography in normal and pregnant mice.
Naunyn Schmiedebergs Arch Pharmacol. 1973;279(4):399-412. doi: 10.1007/BF00500805.
本文引用的文献
1
Effects of ganglion-blocking substances on the small intestine.
J Physiol. 1951 May;113(4):483-505. doi: 10.1113/jphysiol.1951.sp004590.
2
The neuromuscular blocking properties of a series of bis-quaternary tropeines.
Br J Pharmacol Chemother. 1960 Mar;15(1):71-81. doi: 10.1111/j.1476-5381.1960.tb01212.x.
3
NON-DEPOLARISING NEUROMUSCULAR BLOCKADE BY 3-ALPHA,17-ALPHA-BIS(QUATERNARY AMMONIUM) 5-ALPHA-ANDROSTANES.
J Pharm Pharmacol. 1965 Jan;17:55-8. doi: 10.1111/j.2042-7158.1965.tb07569.x.
4
[CURARIZING ACTIVITY OF 3-BETA,20-ALPHA-BISTRIMETHYLAMMONIUM-5-ALPHA-PREGNANE DICHLORIDE (MALOUETINE) AND OF ITS STEREOISOMERS].
Arch Int Pharmacodyn Ther. 1964 Jan 1;147:209-19.
5
Studies on the repetitive discharges evoked in motor nerve and skeletal muscle after injection of anticholinesterase drugs.
Br J Pharmacol Chemother. 1963 Apr;20(2):326-44. doi: 10.1111/j.1476-5381.1963.tb01472.x.
6
Neuromuscular blockade by streptomycin and dihydrostreptomycin.
Br J Pharmacol Chemother. 1960 Dec;15(4):506-9. doi: 10.1111/j.1476-5381.1960.tb00271.x.
7
Assay of histamine on the isolated guinea-pig intestine by the method of superfusion.
Br J Pharmacol Chemother. 1954 Sep;9(3):360-6. doi: 10.1111/j.1476-5381.1954.tb01693.x.
8
The pharmacological properties of "laudolissin" a long-acting curarizing agent.
Br J Pharmacol Chemother. 1952 Sep;7(3):398-408. doi: 10.1111/j.1476-5381.1952.tb00707.x.
9
The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man.
Br J Anaesth. 1967 Oct;39(10):775-80. doi: 10.1093/bja/39.10.775.
10
Neuromuscular blocking properties of stereoisomeric androstane-3,l7-bisquaternary ammonium salts.
Br J Pharmacol Chemother. 1967 May;30(1):194-202. doi: 10.1111/j.1476-5381.1967.tb02125.x.
Zotero 插件